ESR1 and breast carcinoma: After synthesizing m‐PROTAC‐1 by IVT‐mRNA technology (Figure S1), we assessed the expression of the p‐PROTAC firstly in the ERα‐positive breast cancer cell line Michigan Cancer Foundation‐7 (MCF‐7) cells.